Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study

NCT ID: NCT01634477

Last Updated: 2024-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

816 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. To describe the morbidity and clinical characteristics among HIV-infected patients and HIV-uninfected patients.
2. To identify the risk factors for the complication or morbidity among HIV-infected patients and HIV-uninfected patients.
3. To describe the mortality among HIV-infected patients and HIV-uninfected patients.
4. To identify the risk factors for the cause of death among HIV-infected and HIV-uninfected patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The information obtained from this study would be very important in planning future holistic care of HIV-infected patients in our institutes as well as in national policy. Results from the study could be used to develop proper long-term management guidelines for people living with HIV (PLHIV) in Thailand targeted at preventable conditions such as metabolic diseases and certain cancers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIV-infected patients group

HIV positive

No interventions assigned to this group

HIV-uninfected patients group

HIV negative

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

HIV-infected patients group

* HIV positive
* 30 years of age or older, both male and female
* Thai nationality
* Written research informed consent

HIV-uninfected patients group

* HIV un-infected
* 30 years of age or older, both male and female
* Thai nationality
* Written research informed consent

Exclusion Criteria

HIV-infected patients group

* Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment
* Fasting blood sugar \> 126 mg/dl or on the treatment
* Proteinuria
* Creatinine \> 1.5 mg/dl
* Recent hospitalization
* Patient who are having mental disease HIV-uninfected patients group
* Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment
* Fasting blood sugar \> 126 mg/dl or on the treatment
* Proteinuria
* Creatinine \> 1.5 mg/dl
* Recent hospitalization
* Patient who are having mental disease
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HIV Netherlands Australia Thailand Research Collaboration

NETWORK

Sponsor Role collaborator

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV

Sponsor Role collaborator

Chulalongkorn University

OTHER

Sponsor Role collaborator

Queen Savang Vadhana Memorial Hospital, Thailand

OTHER

Sponsor Role collaborator

Thai Red Cross AIDS Research Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Praphan Phanuphak, MD

Role: PRINCIPAL_INVESTIGATOR

The Thai Red Cross AIDS Research Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Thai Red Cross AIDS Research Centre

Pathum Wan, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TNT-HIV 003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Liver Diseases in PLWH
NCT04446156 UNKNOWN
Progress Adult Study
NCT01328275 COMPLETED